Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Retraction: Role of mesenchymal stem cells versus angiotensin converting enzyme inhibitor in kidney repair.

Animal Study on Neuroinflammation, published in Nephrology (Carlton) (2024) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Nephrology (Carlton) (2024)
Country
Australia
Reported sample size
—
Source database
PubMed
PMID
38341878
DOI
10.1111/nep.14278

Abstract (original English)

The retraction has been agreed due to duplications within Figure 2 and the inclusion of figure elements in Figure 1 and 2 that were previously published [1-4]. Thus, the conclusions of this article are considered invalid. The authors have been informed of the decision to retract but did not agree with it. References: 1. Hanaa H. Ahmeda, Wafaa Gh. Shoushab, El-Sayed M. El-Sayed Mahdyb, Laila A. Rashedc, Sara M. Abdob (2013), Influence of adipose tissue derived mesenchymal stem cells in combination with injectable bone substitute on osteoclastogenesis in osteoporotic rats. J Appl Pharm Sci, 3: 046-056. https://doi.org/10.7324/JAPS.2013.3809 2. Salem, A.M., Ahmed, H.H., Atta, H.M., Ghazy, M.A. and Aglan, H.A. (2014), RETRACTED: Potential of bone marrow mesenchymal stem cells in management of Alzheimer's disease in female rats. Cell Biol Int, 38: 1367-1383. https://doi.org/10.1002/cbin.10331 3. Ahmed H, Salem A, Atta H, Ghazy M, Aglan H. RETRACTED: Do adipose tissue-derived mesenchymal stem cells ameliorate Parkinson's disease in rat model? Human & Experimental Toxicology. 2014;33(12):1217-1231. doi: 10.1177/0960327114524238 4. Ahmed, H.H., Metwally, F.M., Khalil, W.K.B. et al. Bone marrow derived mesenchymal stem cells: A unique cytotherapy for rescuing degenerated dopaminergic neurons. Neurochem. J. 9, 284-294 (2015). https://doi.org/10.1134/S1819712415040029.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research